Annual Long Term Debt
$3.77 M
-$468.00 K-11.05%
December 31, 2023
Summary
- As of February 8, 2025, ACRV annual long term debt is $3.77 million, with the most recent change of -$468.00 thousand (-11.05%) on December 31, 2023.
- During the last 3 years, ACRV annual long term debt has risen by +$3.77 million (+100.00%).
- ACRV annual long term debt is now -24.11% below its all-time high of $4.96 million, reached on December 31, 2021.
Performance
ACRV Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$2.97 M
-$270.00 K-8.33%
September 30, 2024
Summary
- As of February 8, 2025, ACRV quarterly long term debt is $2.97 million, with the most recent change of -$270.00 thousand (-8.33%) on September 30, 2024.
- Over the past year, ACRV quarterly long term debt has dropped by -$671.00 thousand (-18.41%).
- ACRV quarterly long term debt is now -40.11% below its all-time high of $4.96 million, reached on December 1, 2021.
Performance
ACRV Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
ACRV Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -11.1% | -18.4% |
3 y3 years | +100.0% | -18.4% |
5 y5 years | +100.0% | -18.4% |
ACRV Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -24.1% | at low | -40.1% | at low |
5 y | 5-year | -24.1% | -100.0% | -40.1% | at low |
alltime | all time | -24.1% | -100.0% | -40.1% | at low |
Acrivon Therapeutics Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.97 M(-8.3%) |
Jun 2024 | - | $3.24 M(-7.4%) |
Mar 2024 | - | $3.50 M(-7.1%) |
Dec 2023 | $3.77 M | $3.77 M(+3.4%) |
Sep 2023 | - | $3.64 M(-5.3%) |
Jun 2023 | - | $3.85 M(-4.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2023 | - | $4.05 M(-4.5%) |
Dec 2022 | $4.24 M(-14.7%) | $4.24 M(-4.2%) |
Sep 2022 | - | $4.42 M(-4.0%) |
Jun 2022 | - | $4.60 M(-7.3%) |
Dec 2021 | $4.96 M(>+9900.0%) | - |
Dec 2021 | - | $4.96 M |
Dec 2020 | $0.00 | - |
FAQ
- What is Acrivon Therapeutics annual long term debt?
- What is the all time high annual long term debt for Acrivon Therapeutics?
- What is Acrivon Therapeutics annual long term debt year-on-year change?
- What is Acrivon Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Acrivon Therapeutics?
- What is Acrivon Therapeutics quarterly long term debt year-on-year change?
What is Acrivon Therapeutics annual long term debt?
The current annual long term debt of ACRV is $3.77 M
What is the all time high annual long term debt for Acrivon Therapeutics?
Acrivon Therapeutics all-time high annual long term debt is $4.96 M
What is Acrivon Therapeutics annual long term debt year-on-year change?
Over the past year, ACRV annual long term debt has changed by -$468.00 K (-11.05%)
What is Acrivon Therapeutics quarterly long term debt?
The current quarterly long term debt of ACRV is $2.97 M
What is the all time high quarterly long term debt for Acrivon Therapeutics?
Acrivon Therapeutics all-time high quarterly long term debt is $4.96 M
What is Acrivon Therapeutics quarterly long term debt year-on-year change?
Over the past year, ACRV quarterly long term debt has changed by -$671.00 K (-18.41%)